N-trans-feruloyltyramine inhibits LPS-induced NO and PGE2 production in RAW 264.7 macrophages: Involvement of AP-1 and MAP kinase signalling pathways

Chemico-Biological Interactions

Volumn 235, Issue , 2015, Pages 56-62

  Jiang, Yunyao ^a   Yu, Lingling ^b,c   Wang, Myeong Hyeon ^a  

^a Kangwon National University   (South Korea)

^b INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^c CHINA THREE GORGES UNIVERSITY   (China)

Author keywords

Anti inflammatory; Cyclooxygenase 2; Inducible nitric oxide synthase; Lipopolysaccharide; N trans feruloyltyramine

Indexed keywords

CYCLOOXYGENASE 2; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; N FERULOYLTYRAMINE; NITRIC OXIDE; PLANT MEDICINAL PRODUCT; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; COUMARIC ACID; CYTOKINE; FERULOYLTYRAMINE; LIPOPOLYSACCHARIDE; TYRAMINE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARCANGELISIA GUSANLUNG; ARTICLE; CELL NUCLEUS; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MACROPHAGE; METABOLIC INHIBITION; MOUSE; NONHUMAN; PLANT STEM; PROTEIN TRANSPORT; RAW 264.7 CELL LINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR PLANT; ANALOGS AND DERIVATIVES; ANIMAL; CELL LINE; DRUG EFFECTS; HEK293 CELL LINE; METABOLISM; PHOSPHORYLATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; COUMARIC ACIDS; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; HEK293 CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA; TYRAMINE;

EID: 84928113821     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2015.03.029     Document Type: Article

References (37)

1. R.P. Darveau The oral microbial consortium's interaction with the periodontal innate defense system DNA Cell Biol. 28 2009 389 395
2. M.E. Davey, and G.A. O'Toole Microbial biofilms: from ecology to molecular genetics Microbiol. Mol. Biol. Rev. 64 2002 847 867
3. X. Li, K.M. Kolltveit, L. Tronstad, and I. Olsen Systemic diseases caused by oral infection Clin. Microbiol. Rev. 13 2000 547 558
4. H. Tilg, A.R. Moschen, and A. Kaser Suppression of interleukin-17 by type I interferons: a contributing factor in virus-induced immuno suppression? Eur. Cytokine Netw. 20 2009 1 6
5. V. Lobo, A. Patil, A. Phatak, and N. Chandra Free radicals, antioxidants and functional foods: impact on human health Pharmacogn. Rev. 4 2010 118 126
6. L.M. Zhong, Y. Zong, L. Sun, J.Z. Guo, W. Zhang, Y. He, R. Song, W.M. Wang, C.J. Xiao, and D. Lu Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells PLoS ONE 7 2012 e32195
7. 2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators Cell. Mol. Immunol. 3 2006 271 277
8. D. Brambilla, C. Mancuso, M.R. Scuderi, P. Bosco, G. Cantarella, L. Lempereur, G. Di Benedetto, S. Pezzino, and R. Bernardini The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: a point of view for an assessment of the risk/benefit profile Nutr. J. 7 2008 29
9. K. Rahman Studies on free radicals, antioxidants, andco-factors Clin. Interv. Aging 2 2007 219 236
10. E.M. Palsson-McDermott, and L.A. O'Neill Signal transduction by the lipopolysaccharide receptor, toll-like receptor-4 Immunology 113 2004 153 162
11. D. Han, M. Shinohara, M.D. Ybanez, B. Saberi, and N. Kaplowitz Signal transduction pathways involved in drug-induced liver injury Handb. Exp. Pharmacol. 196 2010 267 310
12. T. Suzuki, T.J. Moraes, E. Vachon, H.H. Ginzberg, T.T. Huang, M.A. Matthay, M.D. Hollenberg, J. Marshall, C.A. McCulloch, M.T. Abreu, C.W. Chow, and G.P. Downey Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial Am. J. Respir. Cell Mol. Biol. 33 2005 231 247
13. Y. Son, Y.K. Cheong, N.H. Kim, H.T. Chung, D.G. Kang, and H.O. Pae Mitogen-activated protein kinases and reactive oxygen species: How can ROS activate MAPK pathways? J. Signal Transduct. 2011 2011 792639
14. D. Trachootham, W. Lu, M.A. Ogasawara, R.D. Nilsa, and P. Huang Protective role of N-trans-feruloyltyramine against beta-amyloid peptide-induced neurotoxicity in rat cultured cortical neurons Antioxid. Redox Signal. 10 2008 1343 1374
15. M.S. Cooke, M.D. Evans, M. Dizdaroglu, and J. Lunec Oxidative DNA damage: mechanisms, mutation, and disease FASEB J. 17 2003 1195 1214
16. B. Uttara, A.V. Singh, P. Zamboni, and R.T. Mahajan Oxidative stress and neurodegenerative disease: a review of upstream and downstream antioxidant therapeutic options Curr. Neuropharmacol. 7 2009 65 74
17. A. Cavin, K. Hostettmann, W. Dyatmyko, and O. Potterat Antioxidant and lipophilic constituents of Tinospora crispa Planta Med. 64 1998 393 396
18. M. Efdi, K. Ohguchi, Y. Akao, Y. Nozawa, M. Koketsu, and H. Ishihara Ishihara N-trans-Feruloyltyramine as a melanin biosynthesis inhibitor Biol. Pharm. Bull. 30 2007 1972 1974
19. W. Thangnipon, N. Suwanna, N. Kitiyanant, R. Soi-Ampornkul, P. Tuchinda, B. Munyoo, and S. Nobsathian Protective role of N-trans-feruloyltyramine against beta-amyloid peptide-induced neurotoxicity in rat cultured cortical neurons Neurosci. Lett. 513 2012 229 232
20. H.R. Kim, H.Y. Min, Y.H. Jeong, S.K. Lee, N.S. Lee, and E.K. Seo Cytotoxic constituents from the whole plant of Corydalis pallida Arch. Pharm. Res. 28 2005 1224 1227
21. T. Yokozawa, T. Tanaka, and T. Kimura Examination of the nitric oxide production-suppressing component in Tinospora tuberculata Biol. Pharm. Bull. 24 2001 1153 1156
22. M. Philip, D.A. Rowley, and H. Schreiber Inflammation as a tumor promoter in cancer induction Semin. Cancer Biol. 14 2004 433 439
23. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
24. I. Posadas, M.C. Terencio, I. Guillen, M.L. Ferrandiz, J. Coloma, M. Paya, and M.J. Alcaraz Co-expression between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation Naunyn Schmiedebergs Arch. Pharmacol. 361 2000 98 106
25. X. Niu, W. Xing, W. Li, T. Fan, H. Hu, and Y. Li Isofraxidin exhibited anti-inflammatory effects in vivo and inhibited TNF-α production in LPS-induced mouse peritoneal macrophages in vitro via the MAPK pathway Int. Immunopharmacol. 14 2012 164 171
26. L. Zuo, N.P. Otenbaker, B.A. Rose, and K.S. Salisbury Molecular mechanisms of reactive oxygen species-related pulmonary inflammation and asthma Mol. Immunol. 56 2013 57 63
27. J.H. Jang, and Y.J. Surh AP-1 mediates β-amyloid-induced iNOS expression in PC12 cells via the ERK2 and p38 MAPK signaling pathways Biochem. Biophys. Res. Commun. 331 2005 1421 1428
28. J. Hambleton, S.J. Weunstein, L. Lem, and A.L. DeFranco Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages Proc. Natl. Acad. Sci. USA 93 1996 2774 2778
29. C.B. Martin, and B.K. Martin Characterization of the murine C3a receptor enhancer-promoter: expression control by an activator protein 1 sequence and an Ets-like sit J. Immunol. 175 2005 3123 3132
30. J.J. Li, Y. Cao, M.R. Young, and N.H. Colbum Induced expression of dominant-negative c-jun downregulates NFkappaB and AP-1 target genes and suppresses tumor phenotype in human keratinocytes Mol. Carcinog. 29 2000 159 169
31. F. Bost, M. Aouadi, L. Caron, and B. Binetruy The role of MAPKs in adipocyte differentiation and obesity Biochimie 87 2005 51 56
32. J. Chun, R.J. Choi, S. Khan, D.S. Lee, Y.C. Kim, Y.J. Nam, D.U. Lee, and Y.S. Kim Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells Int. Immunopharmacol. 14 2012 375 383
33. Y.C. Hseu, K.J.S. Kumar, C.S. Chen, H.J. Cho, S.W. Lin, P.C. Shen, C.W. Lin, F.J. Lu, and H.L. Yang Humic acid in drinking well water induces inflammation through reactive oxygen species generation and activation of nuclear factor-κB/activator protein-1 signaling pathways: a possible role in atherosclerosis Toxicol. Appl. Pharmacol. 274 2014 249 262
34. R.M. Huff Signal transduction pathways modulated by the D2 subfamily of dopamine receptors Cell. Signal. 8 1996 453 459
35. 1-adrenergic receptor subtypes J. Neurochem. 72 1999 2388 2396
36. E. Kiyokawa, S. Takai, M. Tanaka, T. Iwase, M. Suzuki, Y.Y. Xiang, Y. Naito, K. Yamada, H. Sugimura, and I. Kino Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors Cancer Res. 54 1994 3645 3650
37. R. Winzen, M. Kracht, B. Ritter, A. Wilhelm, C.Y. Chen, A.B. Shyu, M. Muller, M. Gaestel, K. Resch, and H. Holtmann The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism EMBO J. 18 1999 4969 4980